Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Stealth Biotherapeutics Corp ADR (MITO)

Stealth Biotherapeutics Corp ADR (MITO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics (MITO) Sees Hammer Chart Pattern: Time to Buy?

Stealth BioTherapeutics (MITO) has been struggling lately, but the selling pressure may be coming to an end soon.

MITO : 1.3800 (unch)
Stealth BioTherapeutics Joins the Rare Disease Company Coalition

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Thinking about buying stock in Stealth BioTherapeutics, BlackBerry, Ideanomics, Seelos Therapeutics, or Altimmune?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MITO, BB, IDEX, SEEL, and ALT.

ALT : 9.07 (+0.11%)
IDEX : 2.37 (-2.07%)
MITO : 1.3800 (unch)
SEEL : 2.25 (-2.60%)
BB : 10.16 (-1.84%)
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Barth Syndrome

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Thinking about buying stock in Stealth BioTherapeutics, AMC Entertainment, XpresSpa, Western Copper and Gold, or Dolphin Entertainment?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MITO, AMC, XSPA, WRN, and DLPN.

AC : 37.69 (-2.31%)
WRN : 1.9400 (+1.04%)
DLPN : 7.84 (-1.75%)
MITO : 1.3800 (unch)
XSPA : 1.6200 (-0.61%)
AMC : 37.02 (-2.91%)
Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics Announces Poster Presentation at American College of Cardiology (ACC) Annual Meeting

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in May

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics to Report First Quarter Financial Results on Tuesday, May 18, 2021

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Thinking about buying stock in Stealth BioTherapeutics, Rocket Comp, Cocrystal Pharma, AMC Entertainment, or Nokia?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MITO, RKT, COCP, AMC, and NOK.

AC : 37.69 (-2.31%)
COCP : 1.1600 (-3.33%)
MITO : 1.3800 (unch)
AMC : 37.02 (-2.91%)
NOK : 6.08 (+0.50%)
RKT : 17.24 (-1.32%)
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics Announces Poster Presentation at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics CEO to Give Keynote Presentation at Mitochondria-Targeted Drug Development Summit

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics Announces Promotion of Marty Redmon to Chief Research & Development Officer

, /PRNewswire/ -- Stealth BioTherapeutics (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in March

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.3800 (unch)

Barchart Exclusives

When Weather and Weather Derivatives Diverge
A look at the softs complex Friday morning shows us markets aren't looking at weather in Brazil to close out the month. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar